Lisch nodule pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) Created page with "{{Lisch nodule}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Oncology {{WikiDoc Help Menu}} {{WikiDoc..." |
|||
| (5 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Lisch nodule}} | {{Lisch nodule}} | ||
{{CMG}} | {{CMG}}{{Swathi}} | ||
== | ==Pathophysiology of Lisch Nodule== | ||
*A hamartoma is defined as a benign tumor or nodular growth that is composed of proliferating mature histologically normal cells that normally reside at the affected tissue | |||
**In ophthalmic jargon, iris hamartomas traditionally refer to Lisch nodules which are encountered in patients with neurofibromatosis type 1 (NF1). | |||
*NF1 is due to mutations in the NF1 gene, located at chromosome 17q11.2 | |||
*Neurofibromin, the protein product encoded by the gene, is expressed in many tissues, including brain, kidney, spleen, and thymus | |||
*Mutations in the NF1 gene result in loss of production or reduced function of protein; this causes a wide spectrum of clinical findings, including NF1-associated tumors | |||
*Histopathologically, Lisch nodules are composed of melanocytes and spindle cells, usually concentrated on the superficial layers of the iris stroma. <ref name="Kiratli2011">{{cite journal|last1=Kiratli|first1=H|title=Head and Neck: Iris Hamartomas|journal=Atlas of Genetics and Cytogenetics in Oncology and Haematology|issue=1|year=2011|issn=1768-3262|doi=10.4267/2042/44673}}</ref> | |||
*The spindle cells are larger than the normal iris melanocytes. | |||
*Immunohistochemical studies show positive reaction against vimentin, smooth muscle actin and neuron specific enolase. | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category: | [[Category: Needs content]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Ophthalmology]] | |||
Latest revision as of 14:26, 12 June 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Swathi Venkatesan, M.B.B.S.[2]
Pathophysiology of Lisch Nodule
- A hamartoma is defined as a benign tumor or nodular growth that is composed of proliferating mature histologically normal cells that normally reside at the affected tissue
- In ophthalmic jargon, iris hamartomas traditionally refer to Lisch nodules which are encountered in patients with neurofibromatosis type 1 (NF1).
- NF1 is due to mutations in the NF1 gene, located at chromosome 17q11.2
- Neurofibromin, the protein product encoded by the gene, is expressed in many tissues, including brain, kidney, spleen, and thymus
- Mutations in the NF1 gene result in loss of production or reduced function of protein; this causes a wide spectrum of clinical findings, including NF1-associated tumors
- Histopathologically, Lisch nodules are composed of melanocytes and spindle cells, usually concentrated on the superficial layers of the iris stroma. [1]
- The spindle cells are larger than the normal iris melanocytes.
- Immunohistochemical studies show positive reaction against vimentin, smooth muscle actin and neuron specific enolase.
References
- ↑ Kiratli, H (2011). "Head and Neck: Iris Hamartomas". Atlas of Genetics and Cytogenetics in Oncology and Haematology (1). doi:10.4267/2042/44673. ISSN 1768-3262.